Cargando…
Genetic Variation in CRHR1 is Associated with Short-Term Respiratory Response to Corticosteroids in Preterm Infants at risk for Bronchopulmonary Dysplasia
BACKGROUND: Bronchopulmonary Dysplasia (BPD) is an orphan disease and advances in prevention and treatment are lacking. Clinical efficacy of systemic corticosteroid therapy to reduce the severity of lung disease and BPD is highly variable. Our objective was to assess whether candidate SNPs in cortic...
Autores principales: | Lewis, Tamorah, Truog, William, Norberg, Mike, Ballard, Philip L., Torgerson, Dara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532775/ https://www.ncbi.nlm.nih.gov/pubmed/30467342 http://dx.doi.org/10.1038/s41390-018-0235-1 |
Ejemplares similares
-
Pharmacometabolomics of Respiratory Phenotypic Response to Dexamethasone in Preterm Infants at Risk for Bronchopulmonary Dysplasia
por: Lewis, Tamorah, et al.
Publicado: (2019) -
Pharmacometabolomics Profiling of Preterm Infants Validates Patterns of Metabolism Associated With Response to Dexamethasone Treatment for Bronchopulmonary Dysplasia
por: Stockard, Bradley, et al.
Publicado: (2022) -
Pharmacoepidemiology of Drug Exposure in Intubated and Non-Intubated Preterm Infants With Severe Bronchopulmonary Dysplasia
por: Lewis, T., et al.
Publicado: (2021) -
Corticosteroids for the prevention of bronchopulmonary dysplasia in preterm infants: a network meta-analysis
por: Zeng, Linan, et al.
Publicado: (2018) -
Utilization of Inhaled Corticosteroids for Infants with Bronchopulmonary Dysplasia
por: Slaughter, Jonathan L., et al.
Publicado: (2014)